Modeling Kinetic Interactions of Chemical Mixtures

about

Modeling Kinetic Interactions of Chemical Mixtures

Item

http://www.wikidata.org/entity/Q57382869

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2010

@uk

name

Modeling Kinetic Interactions of Chemical Mixtures

@en

Modeling Kinetic Interactions of Chemical Mixtures

@nl

type

Item

label

Modeling Kinetic Interactions of Chemical Mixtures

@en

Modeling Kinetic Interactions of Chemical Mixtures

@nl

prefLabel

Modeling Kinetic Interactions of Chemical Mixtures

@en

Modeling Kinetic Interactions of Chemical Mixtures

@nl

P1476

Modeling Kinetic Interactions of Chemical Mixtures

@en

P2093

Harvey J. Clewell

http://www.w3.org/2001/XMLSchema#string

Jerry L. Campbell

http://www.w3.org/2001/XMLSchema#string

Kannan Krishnan

http://www.w3.org/2001/XMLSchema#string

Melvin E. Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane.

Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures.

Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects

Monoclonal antibody-directed characterization of cytochrome P450 isozymes responsible for toluene metabolism in rat liver

Physiologically based pharmacokinetic analyses of simple mixtures.

Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment.

A physiologically based simulation approach for determining metabolic constants from gas uptake data.

Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data.

Role of hepatocellular regeneration and hepatolobular healing in the final outcome of liver injury. A two-stage model of toxicity.

Development and specification of physiologically based pharmacokinetic models for use in risk assessment.

P304

125-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/9783527630196.CH5

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime